Showing results (911-920 of 951) with videos related to

Sort By:
Pageof 96
Lancet (London, England)|February 14, 2021
Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programmeRuth E Langley, Duncan C Gilbert, Trinh Duong, et al.
Lancet (London, England)|July 24, 2020
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trialPedro M Folegatti, Katie J Ewer, Parvinder K Aley, et al.
Cell|September 3, 2013
An interactive resource to identify cancer genetic and lineage dependencies targeted by small moleculesAmrita Basu, Nicole E Bodycombe, Jaime H Cheah, et al.
Biotechnology and Bioengineering|September 29, 2021
Manufacturing a chimpanzee adenovirus-vectored SARS-CoV-2 vaccine to meet global needsCarina C D Joe, Jinlin Jiang, Thomas Linke, et al.
The Journal of Infectious Diseases|October 23, 2014
Evaluation of the efficacy of ChAd63-MVA vectored vaccines expressing circumsporozoite protein and ME-TRAP against controlled human malaria infection in malaria-naive individualsSusanne H Hodgson, Katie J Ewer, Carly M Bliss, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaquesNeeltje van Doremalen, Teresa Lambe, Alexandra Spencer, et al.
Plos One|July 30, 2011
Impact on malaria parasite multiplication rates in infected volunteers of the protein-in-adjuvant vaccine AMA1-C1/Alhydrogel+CPG 7909Christopher J A Duncan, Susanne H Sheehy, Katie J Ewer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 24, 2012
ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humansSusanne H Sheehy, Christopher J A Duncan, Sean C Elias, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 24, 2006
Theileria parva candidate vaccine antigens recognized by immune bovine cytotoxic T lymphocytesSimon P Graham, Roger Pellé, Yoshikazu Honda, et al.
Plos One|March 26, 2013
Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adultsCaroline Ogwang, Muhammed Afolabi, Domtila Kimani, et al.
Pageof 96